tailieunhanh - Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation

Intrahepatic cholangiocarcinoma (ICC) is an aggressive, highly lethal tumors and lacks of effective chemo and targeted therapies. Cell lines and animal models, even partially reflecting tumor characteristics, have limits to study ICC biology and drug response. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN